FENC · Fennec Pharmaceuticals Inc.

Summary

Director Rostislav Raykov will retire at the 2026 annual meeting, and the Board will reduce its size from six to five directors.

Key takeaways

• Director Rostislav Raykov notified the Company of his retirement, effective after the 2026 annual meeting.
• Raykov's departure is not due to any disagreement with the Company.
• The Board will reduce its size from six to five directors, effective after the annual meeting.
• No vacancies are expected on the Board following the meeting.